Double or triple down: how AFT Pharmaceuticals plans to win in China

Double or triple down: how AFT Pharmaceuticals plans to win in China
(Image: Getty)
Rebecca Stevenson
AFT Pharmaceuticals says it has increased manufacturing capacity and brought in market experts as it prepares to launch its antibacterial cream in China. The New Zealand Exchange-listed (NZX) firm reported its results for the 12 months to March 31 on May 23. Its international and Asian sales rose 70%, accounting for 20% of revenue. Operating revenue for AFT’s Asian business grew 57% to $10.7 million from $6.8m, while operating profit rose to $2.5m from $900,000.It said growth was driven through the hospital channel, wi...

More Markets

NZ sharemarket up 0.4% despite inflation report
Markets Market Close

NZ sharemarket up 0.4% despite inflation report

The S&P/NZX 50 Index closed at 13,344.96, up 55.75 points or 0.42%.

What Infratil likes about Contact Energy
Infrastructure

What Infratil likes about Contact Energy

Infratil is keeping its options open, while TECT diversifies.

Disclosure breaches Class action against ANZ NZ continues
Finance

Disclosure breaches Class action against ANZ NZ continues

It comes as retrospective law tweaks fail to give relief.

Kiwi Capital Limited appoints Susan Peterson as chair
Finance

Kiwi Capital Limited appoints Susan Peterson as chair

New chair of Kiwibank parent company Kiwi Capital Ltd brings breadth of experience.